Test offers new way to personalize treatment, reduce unnecessary chemotherapy for patients with breast cancer
A new cancer diagnostic test marketed by Veracyte and developed by a group of researchers, including UNC geneticist Charles Perou, Ph.D., has been found to accurately predict whether patients with breast cancer need chemotherapy ...
Jul 23, 2026
0
7









